Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve

IRCCS Policlinico S. Donato173 enrolled

Overview

Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR). The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes. The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year

Study Type

OBSERVATIONAL

Enrollment

173

Conditions

Failed Transcather Aortic Valve

Interventions

TAVRDEVICE

Trancatheter aortic valve replacement

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR). Exclusion Criteria: \-

Locations (1)

IRCCS Policlinico San Donato

San Donato Milanese, Milan, Italy

Outcomes

Primary Outcomes

Overall mortality

Overall mortality and Cardiovascular mortality at 1 year

Time frame: 1 year

Secondary Outcomes

VARC-3 Events

Cerebrovascular events, bleeding complications, periprocedural MI, conduction disturbances, BVF, procedural success, device success, AKI (all according to VARC-2).

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.